Scientific Reports · 2014 · 47 citations · 35 references
MedicineOncologyPharmacologyCell SignalingMolecular OncologyOncogenesCancer Cell SignalingCancer Stem CellsMetastatic Breast CancerOncogenic Signaling PathwaysSignal Transduction In CancerBreast Cancer ProgressionCancer Signaling PathwaysCancer Stem Cell MarkersMammosphere AssayMetastatic Breast Cancer BiologyOncogenic DysregulationTriple-negative Breast Cancer RecurrenceTriple-negative Breast Cancer Therapy
Breast cancer is the most common malignancy among women and has poor survival and high recurrence rates for aggressive metastatic disease. Notably, triple-negative breast cancer (TNBC) is a highly aggressive cancer and there is no preferred agent for TNBC therapy. In this study, we show that a novel agent, 2-(4-hydroxy-3-methoxyphenyl)-benzothiazole (YL-109), has ability to inhibit breast cancer cell growth and invasiveness in vitro and in vivo. In addition, YL-109 repressed the sphere-forming ability and the expression of stem cell markers in MDA-MB-231 mammosphere cultures. YL-109 increased the expression of carboxyl terminus of Hsp70-interacting protein (CHIP), which suppresses tumorigenic and metastatic potential of breast cancer cells by inhibiting the oncogenic pathway. YL-109 induced CHIP transcription because of the recruitment of the aryl hydrocarbon receptor (AhR) to upstream of CHIP gene in MDA-MB-231 cells. Consistently, the antitumor effects of YL-109 were depressed by CHIP or AhR knockdown in MDA-MB-231 cells. Taken together, our findings indicate that a novel agent YL-109 inhibits cell growth and metastatic potential by inducing CHIP expression through AhR signaling and reduces cancer stem cell properties in MDA-MB-231 cells. It suggests that YL-109 is a potential candidate for breast cancer therapy.
35
Molecular portraits of human breast tumours
Charles M. Perou, Thérese Sørlie, Michael B. Eisen et al. · Nature · 2000 · 16.3K citations
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
Rebecca Dent, Maureen Trudeau, Kathleen I. Pritchard et al. · Clinical Cancer Research · 2007 · 5.1K citations · Full text
Ki67 expression in breast cancer
Mohamed A. Elkablawy, Abdulkader M. Albasri, Rabab Mohammed et al. · Saudi Medical Journal · 2016 · 4.4K citations · Full text
Cancer Stem Cells: An Old Idea—A Paradigm Shift
Max S. Wicha, Suling Liu, Gabriela Dontu · Cancer Research · 2006 · 1.4K citations
Medicine, Cancer Biology, Oncology +13